Trademark: 88944666
Word
ASCLEPIX THERAPEUTICS
Status Date
Thursday, May 2, 2024
Filing Date
Tuesday, June 2, 2020
Published for Opposition
Tuesday, March 9, 2021
5 Therapeutic pharmaceutical for the treatment of retinal diseases; ocular pharmaceuticals
Jun 5, 2020
New Application Entered
Sep 3, 2020
Non-Final Action Written
Jun 24, 2020
New Application Office Supplied Data Entered
Sep 2, 2020
Assigned To Examiner
Sep 3, 2020
Non-Final Action E-Mailed
Sep 3, 2020
Notification Of Non-Final Action E-Mailed
Jan 22, 2021
Correspondence Received In Law Office
Oct 7, 2020
Teas Response To Office Action Received
Jan 20, 2021
Assigned To Lie
Jan 22, 2021
Teas/Email Correspondence Entered
Feb 1, 2021
Approved For Pub - Principal Register
Mar 9, 2021
Official Gazette Publication Confirmation E-Mailed
Feb 17, 2021
Notification Of Notice Of Publication E-Mailed
Mar 9, 2021
Published For Opposition
May 4, 2021
Noa E-Mailed - Sou Required From Applicant
Nov 5, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 3, 2021
Sou Teas Extension Received
Nov 3, 2021
Sou Extension 1 Filed
Nov 3, 2021
Sou Extension 1 Granted
May 4, 2022
Sou Teas Extension Received
May 4, 2022
Sou Extension 2 Filed
May 4, 2022
Sou Extension 2 Granted
May 6, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 25, 2022
Sou Extension 3 Filed
Oct 25, 2022
Sou Teas Extension Received
Oct 25, 2022
Sou Extension 3 Granted
Apr 27, 2023
Sou Extension 4 Filed
Apr 27, 2023
Sou Extension 4 Granted
Apr 29, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 2, 2023
Sou Teas Extension Received
Oct 11, 2023
Case Assigned To Intent To Use Paralegal
Oct 11, 2023
Sou Extension 5 Granted
Oct 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 27, 2023
Sou Teas Extension Received
Oct 2, 2023
Sou Extension 5 Filed
May 1, 2024
Use Amendment Filed
May 1, 2024
Teas Statement Of Use Received
May 2, 2024
Statement Of Use Processing Complete
Oct 12, 2023
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
